BioSpace News Archive

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief Executive Officer Saundra Pelletier will present and host one-on-one meetings at the 14th annual LD Micro Main Event being held in Los Angeles on October 12-14, 2021 .

Aethlon Medical, Inc., a company developing medical technology to treat cancer and life-threatening infectious disease, announced that it has entered into an agreement with PPD, Inc., a leading global contract research organization, for PPD to oversee the company’s clinical studies investigating the Hemopurifier, Aethlon’s therapeutic blood filtration system, for infectious disease indications.

Equillium, Inc. today announced that three abstracts were accepted for presentation at ACR Convergence, the annual meeting of the American College of Rheumatology.

Aytu BioPharma, Inc. announced today that Josh Disbrow, Chairman and Chief Executive Officer will present during two upcoming investor conferences in September

Viridian Therapeutics, Inc. announced today that two posters featuring preclinical data on VRDN-001 and VRDN-002 are scheduled to be presented at the 90th Annual Meeting of the American Thyroid Association (ATA), which is being held from September 30th through October 3rd .

Curebase, a company committed to democratizing access to clinical studies, teamed up again this summer with InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, to test InBios’ SCoV-2 Detect IgG Rapid Test.

Arcutis Biotherapeutics, Inc. announced new patient-reported outcome data that show topical roflumilast provides significant reductions in itch, a common and bothersome symptom of multiple dermatologic conditions.

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, and a subsidiary of Grifols, announced today that it has signed a license agreement with Dutch biotech ProteoNic B.V. for the use of its premium 2G UnicTM technology platform to enable high-yield production of GigaGen’s mono- and polyclonal antibody drug candidates.

PAVmed Inc. announced that on October 26, 2021, from 1 to 3 PM EDT, it will host a virtual investor event focused on its digital health subsidiary Veris Health entitled Veris Heath: Bringing Digital Health to Cancer Care.

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced three poster presentations at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics to be held October 7-10, 2021.